Status:
COMPLETED
Antibacterial and Anti-biofilm Activity of Frankincense Extract Against Porphyromonas Gingivalis
Lead Sponsor:
Tanta University
Conditions:
Periodontal Diseases
Eligibility:
All Genders
25-50 years
Phase:
PHASE1
Brief Summary
Boswellia sacra Flueck. oleoresin extract (frankincense) was traditionally used in the treatment of different diseases as respiratory, rheumatoid arthritis, and bacterial infections. Therefore, the an...
Detailed Description
The study was carried out on 30 systemically healthy patients of both sexes their ages ranged from 25 to 50 years old, diagnosed with moderate to severe chronic periodontitis (grade III stage b period...
Eligibility Criteria
Inclusion
- patients with grade III stage b periodontitis , patients who have the willing to participate in the study and informed consents will be taken from them
Exclusion
- patients who are under antibiotic therapy or any antimicrobial drugs
- smokers
Key Trial Info
Start Date :
January 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04705714
Start Date
January 15 2021
End Date
March 1 2021
Last Update
July 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Malak Mohamed Shoukheba
Tanta, Egypt, 020